MAPT and Alzheimer disease: On the other hand, intestinal metabolites are also an important issue (more than 100 different metabolites are known) and may have pro-inflammatory effects, increasing the aggregation of amyloid and tau proteins in the brain, but a direct link between intestinal metabolites and AD pathogenesis has not been demonstrated [73,74].